Pearl Therapeutics
A company developing products to treat respiratory diseases, including chronic obstructive pulmonary disease
All edits
On October 19, 2010 Pearl Therapeutics completed their series C funding round with $69 million in funding from Vatera Healthcare Partners (lead investor), New Leaf Venture Partners, and 5AM Ventures.
On October 1, 2012 Pearl Therapeutics completed a private equity fundraising round with $23.3 million in funding from Vatera Healthcare Partners, New Leaf Venture Partners, Clarus Ventures, and 5AM Ventures.
On November 13, 2012 Pearl Therapeutics completed their series D funding round with $65 million in funding from Vetera Healthcare Partners (lead investor), New Leaf Venture Partners, Clarus Ventures, and 5AM Ventures.
On April 1, 2013 Pearl Therapeutics completed a venture funding round with $41.7 million in funding from Vatera Healthcare Partners (lead investor), New Leaf Venture Partners, Clarus Ventures, and 5AM Ventures.
On October 19, 2010 Pearl Therapeutics completed their series C funding roundfunding round with $69 million in funding from Vatera Healthcare Partners (lead investor), New Leaf Venture Partners, and 5AM Ventures.
On October 19, 2010 Pearl Therapeutics completed their series C funding round with $69 million in funding from Vatera Healthcare Partners (lead investor), New Leaf Venture PartnersNew Leaf Venture Partners, and 5AM Ventures.
Find more companies like Pearl Therapeutics
